🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07359144
Recruiting Not applicable

Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women

NCT07359144 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-01-22
Last updated
2026-01-23

Condition(s) studied

Pilates ExercisesNonspecificLow Back PainPostnatal Women

Investigational drug(s) / intervention(s)

Pilates program + Home exercise programHome exercise program

Pilates program + Home exercise program: Patients will do a comprehensive exercise consisting of a home exercise program (bridges, bridge with leg extension (bridge dog), back extensions, spine twist, and child's pose), a Pilates program, and oral paracetamol as needed for pain relief.

Home exercise program: Patients will perform a home-based exercise program consisting solely of postural correction exercises.

Study summary

This study aims to investigate the effects of Pilates for postnatal women with Non-specific low back pain (NSLBP).

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria: * Age ranges from 20 and 30 years old. * Body mass index (BMI) doesn't exceed 30 kg/m2. * Patients who are referred from a gynecologist with a diagnosis of nonspecific low back pain. * Patients who have pain for more than three months. * Patients who have parity ranging from one to three (to control the extreme physiological changes from multiple childbirths, ensuring a more uniform sample). * Patients who have score more than 4 on the Visual Analog Scale (VAS). Exclusion Criteria: * Mechanical low back pain (LBP). * Women who had performed any spinal surgery e.g. unilateral hemilaminectomy or microdiscectomy. * Women with history of vertebral fracture or trauma. * Women with systemic disorder e.g. diabetes mellitus. * Women who are pregnant. * Women who had received physiotherapy treatment for their LBP one month before the start of this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kafrelsheikh University (Faculty of Physical Therapy) Kafr ash Shaykh Kafrelsheikh Recruiting

More Kafrelsheikh University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07359144 on ClinicalTrials.gov ↗ ← All trials in Egypt